Among participants in the landmark ORAL Surveillance study assigned to the JAK inhibitor tofacitinib (Xeljanz) and also using ...

From a new market intelligence platform to an AI-powered smart wallet, these technologies are changing the way we think of ...

Pfizer plans to launch Prevnar 20, a new pneumococcal vaccine, in Korea early next year, offering broader protection than ...

Pfizer's latest COVID booster targets Omicron JN.1. Learn who should get it and why it’s essential for protection.

A Las Vegas woman is not only fighting for her life, but also against a pharmaceutical company after her tumors could be ...

Robert F. Kennedy Jr.'s nonprofit, Children’s Health Defense, is involved in vaccine lawsuits against agencies he could wind ...

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. Here's why these two high-yield ...

The Trump presidency and mooted ascension of prominent vaccination opponent Robert F. Kennedy Junior to head the US ...

The agency's openness to a targeted pivotal study shows it’s still willing to consider accelerated clearance for Duchenne ...

In another sign of biopharma's waning interest in the traditional ex vivo gene therapy approach, CSL Behring is shutti | CSL ...

Biotech-stock investing has one tough test for success - and it's about to get easier ...

Regenxbio’s investigational gene therapy improved muscle function for patients with Duchenne muscular dystrophy (DMD) in a phase 1/2 study. | Regenxbio’s investigational gene therapy improved muscle ...